Perrigo (PRGO) Revenue Growth (1y) (2013 - 2026)
Perrigo (PRGO) Revenue Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -3.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -3.17% |
| Mar 28, 2026 | -7.16% |
| Dec 31, 2025 | -2.52% |
| Sep 27, 2025 | -4.06% |
| Jun 28, 2025 | -0.86% |
| Mar 29, 2025 | -3.53% |
| Dec 31, 2024 | -1.61% |
| Sep 28, 2024 | -3.23% |
| Jun 29, 2024 | -10.69% |
| Mar 30, 2024 | -8.43% |
| Dec 31, 2023 | 0.14% |
| Sep 30, 2023 | 2.15% |
| Jul 1, 2023 | 6.37% |
| Apr 1, 2023 | 9.98% |
| Dec 31, 2022 | 4.56% |
| Oct 1, 2022 | 5.51% |
| Jul 2, 2022 | 14.33% |
| Apr 2, 2022 | 6.39% |
| Dec 31, 2021 | -14.32% |
| Oct 2, 2021 | 3.96% |